History | Drug misuse prevention: targeted interventions | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Consultation comments published

Consultation comments and responses (PDF 1.37 MB)

Published:

22 February 2017

Equality and health inequalities assessment

Equality impact assessment (PDF 252 KB)

Published:

22 February 2017

Stakeholder list updated

Stakeholder list (PDF 403 KB)

Published:

22 February 2017

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 589 KB)

Published:

20 July 2016
Equality impact assessment (PDF 189 KB)

Published:

20 July 2016
Comments form (MSWord 92 KB)

Published:

20 July 2016
Economic report (PDF 1.83 MB)

Published:

20 July 2016
Economic report Cost effectiveness (PDF 695 KB)

Published:

20 July 2016
Expert report Peter Burkinshaw (PDF 240 KB)

Published:

20 July 2016
Expert report Jim McVeigh (PDF 120 KB)

Published:

20 July 2016
Expert report Simon Moore (PDF 83 KB)

Published:

20 July 2016
Evidence statements (PDF 456 KB)

Published:

20 July 2016
Evidence review (PDF 968 KB)

Published:

20 July 2016
Evidence review Appendix 1 (PDF 1.26 MB)

Published:

20 July 2016
Evidence review Appendix 2 (PDF 895 KB)

Published:

20 July 2016
Evidence review Appendix 3 (PDF 329 KB)

Published:

20 July 2016
Evidence review 2 (PDF 751 KB)

Published:

20 July 2016
Evidence review 2 Appendix 1 (PDF 639 KB)

Published:

20 July 2016
Evidence review 2 Appendix 2 (PDF 950 KB)

Published:

20 July 2016
Evidence review 2 Appendix 3 (PDF 194 KB)

Published:

20 July 2016

Committee meetings

Committee meeting: documents
Minutes 5 Nov 2015 (PDF 273 KB)

Published:

05 August 2016
Minutes 17 Dec 2015 (PDF 217 KB)

Published:

05 August 2016
Minutes 28 Jan 2016 (PDF 214 KB)

Published:

01 September 2016
Minutes 3 Mar 2016 (PDF 211 KB)

Published:

01 September 2016
Minutes 25 & 26 April 2016 (PDF 159 KB)

Published:

19 October 2016
Minutes 11 Oct 2016 (PDF 341 KB)

Published:

30 November 2016
Minutes 12 Oct 2016 (PDF 330 KB)

Published:

30 November 2016

Pre-consultation documents released

Economic plan (PDF 86 KB)

Published:

08 June 2016
Review protocols for review 1 (PDF 105 KB)

Published:

08 June 2016
Search strategies for review 1 (PDF 229 KB)

Published:

08 June 2016
Review protocols for review 2 (PDF 141 KB)

Published:

08 June 2016
Search strategies for review 2 (PDF 231 KB)

Published:

08 June 2016
Economic plan Modelling report (MSWord 1.94 MB)

Published:

13 June 2016

Committee list updated

Committee member list (PDF 312 KB)

Published:

22 February 2017

Call for evidence

Call for evidence information

Final scope

Final scope
Final scope (PDF 203 KB)

Published:

13 May 2015

Draft scope shareholder comments and responses table

Draft scope shareholder comments and responses table
Draft scope shareholder comments and responses table (PDF 453 KB)

Published:

13 May 2015

Final equality impact assessment

Final equality impact assessment
Final equality impact assessment (PDF 99 KB)

Published:

13 May 2015

Scope consultation

Scope consultation information
Draft scope
Draft scope (PDF 205 KB)

Published:

03 March 2015
Equality impact assessment
Equality impact assessment (PDF 91 KB)

Published:

03 March 2015